A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
出版年份 2017 全文链接
标题
A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
作者
关键词
-
出版物
Nature Communications
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-11-04
DOI
10.1038/s41467-017-01565-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Precise glioblastoma targeting by AS1411 aptamer-functionalized poly ( l -γ-glutamylglutamine)–paclitaxel nanoconjugates
- (2017) Zimiao Luo et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy
- (2017) Nicola L. Diny et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neoadjuvant nab-paclitaxel in breast cancer: trial results and patient care
- (2016) Marco Colleoni LANCET ONCOLOGY
- Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial
- (2016) Christoph Zielinski et al. LANCET ONCOLOGY
- Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial
- (2016) Michael Untch et al. LANCET ONCOLOGY
- Phase II trial of weekly nab-paclitaxel for previously treated advanced non–small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301
- (2016) Shinya Sakata et al. LUNG CANCER
- Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer
- (2016) Anthony F. Yu et al. ONCOLOGIST
- The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia
- (2015) Tim J Schuijt et al. GUT
- Nucleolin targeting AS1411 aptamer modified pH-sensitive micelles: A dual-functional strategy for paclitaxel delivery
- (2015) Jinming Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers
- (2015) Xiaoli Yi et al. MOLECULAR PHARMACEUTICS
- Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy
- (2015) Chao Liang et al. NATURE MEDICINE
- Crystal structure reveals specific recognition of a G-quadruplex RNA by a β-turn in the RGG motif of FMRP
- (2015) Nikita Vasilyev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Extent of Irradiation-Induced Long-Term Visceral Organ Damage Depends on Cranial/Brain Exposure
- (2015) François-Xavier Boittin et al. PLoS One
- Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas
- (2014) Liyu Li et al. BIOMATERIALS
- Nucleic Acid Aptamer-Mediated Drug Delivery for Targeted Cancer Therapy
- (2014) Huijie Zhu et al. ChemMedChem
- Paclitaxel-Loaded PEG-PE-Based Micellar Nanopreparations Targeted with Tumor-Specific Landscape Phage Fusion Protein Enhance Apoptosis and Efficiently Reduce Tumors
- (2014) T. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Development of Aptamer oligonucleotides as Anticoagulants and Antithrombotics for Cardiovascular Diseases: Current Status
- (2014) Weibin Li et al. THROMBOSIS RESEARCH
- Aptamers as Promising Molecular Recognition Elements for Diagnostics and Therapeutics in the Central Nervous System
- (2014) Erin M. McConnell et al. Nucleic Acid Therapeutics
- A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
- (2013) Jonathan E. Rosenberg et al. INVESTIGATIONAL NEW DRUGS
- Nucleolin Targeting AS1411 Modified Protein Nanoparticle for Antitumor Drugs Delivery
- (2013) Jinhui Wu et al. MOLECULAR PHARMACEUTICS
- Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab
- (2012) Chamaida Plasencia et al. ANNALS OF THE RHEUMATIC DISEASES
- Nucleic acid aptamers: an emerging frontier in cancer therapy
- (2012) Guizhi Zhu et al. CHEMICAL COMMUNICATIONS
- Nanoformulation of paclitaxel to enhance cancer therapy
- (2012) Quanrong Gu et al. JOURNAL OF BIOMATERIALS APPLICATIONS
- Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity
- (2012) Liang Liang et al. JOURNAL OF CONTROLLED RELEASE
- Lysosomal Acidification Mechanisms
- (2011) Joseph A. Mindell Annual Review of Physiology
- Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
- (2011) Jianwei Guo et al. BIOMATERIALS
- A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism
- (2010) E. M. Reyes-Reyes et al. CANCER RESEARCH
- Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies
- (2010) V.A. Carozzi et al. EXPERIMENTAL NEUROLOGY
- Drug delivery and nanoparticles: Applications and hazards
- (2010) de Jong International Journal of Nanomedicine
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- Minireview: Nanoparticles and the Immune System
- (2009) Banu S. Zolnik et al. ENDOCRINOLOGY
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
- (2009) S. Soundararajan et al. MOLECULAR PHARMACOLOGY
- NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway
- (2009) N Jinawath et al. ONCOGENE
- Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker
- (2008) Marina Devetzi et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More